Frohlich Tom Insider Trades

Insider Trading History

Track insider trading activity for Frohlich Tom. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Jade Biosciences
Jade Biosciences JBIO
Chief Executive Officer
Holding Value $10.4M 472,500 shares
Last Trade
Feb 12, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.16M 551,250 shares
$14.81
$21.97
Jade Biosciences
Jade Biosciences JBIO
Chief Executive Officer
Holding Value $132k 6,000 shares
Last Trade
May 16, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
No data
No data
$21.97
Jade Biosciences
Jade Biosciences JBIO
Chief Executive Officer
Holding Value $0 0 shares
Last Trade
Apr 28, 2025 Sale
No data
No data
$21.97
Chinook Therapeutics
Chinook Therapeutics KDNY
Chief Operating Officer
Holding Value $0 0 shares
Last Trade
Aug 11, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$24.1M 596,817 shares
$40.39
$40.39
Chinook Therapeutics
Chinook Therapeutics KDNY
Chief Operating Officer
Holding Value $6.09M 150,777 shares
Last Trade
Feb 10, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$87.9k 3,700 shares
$23.75
$40.39
Chinook Therapeutics
Chinook Therapeutics KDNY
Chief Operating Officer
Holding Value $275k 6,801 shares
Last Trade
Feb 10, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$164k 6,803 shares
$24.13
$40.39
Chinook Therapeutics
Chinook Therapeutics KDNY
Chief Operating Officer
Holding Value $6.24M 154,477 shares
Last Trade
Feb 10, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$164k 6,803 shares
$24.13
$40.39
Chinook Therapeutics
Chinook Therapeutics KDNY
Chief Operating Officer
Holding Value $5.96M 147,674 shares
Last Trade
Jan 31, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$113k 4,566 shares
$24.68
$40.39
Chinook Therapeutics
Chinook Therapeutics KDNY
Chief Operating Officer
Holding Value $3.39M 84,000 shares
Last Trade
Jan 31, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.65M 105,000 shares
$25.27
$40.39
Chinook Therapeutics
Chinook Therapeutics KDNY
Chief Operating Officer
Holding Value $6.15M 152,240 shares
Last Trade
Jan 31, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$211k 8,333 shares
$25.27
$40.39
Chinook Therapeutics
Chinook Therapeutics KDNY
Chief Operating Officer
Holding Value $673k 16,667 shares
Last Trade
Jan 31, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$211k 8,333 shares
$25.27
$40.39
Chinook Therapeutics
Chinook Therapeutics KDNY
Chief Operating Officer
Holding Value $5.81M 143,907 shares
Last Trade
Dec 13, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$250k 10,000 shares
$25.00
$40.39
Chinook Therapeutics
Chinook Therapeutics KDNY
Chief Operating Officer
Holding Value $1.77M 43,847 shares
Last Trade
Dec 13, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$250k 10,000 shares
$25.03
$40.39
Chinook Therapeutics
Chinook Therapeutics KDNY
Chief Operating Officer
Holding Value $6.22M 153,907 shares
Last Trade
Dec 13, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$250k 10,000 shares
$25.03
$40.39
Chinook Therapeutics
Chinook Therapeutics KDNY
Chief Operating Officer
Holding Value $2.17M 53,847 shares
Last Trade
Nov 07, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$226k 10,000 shares
$22.56
$40.39
Chinook Therapeutics
Chinook Therapeutics KDNY
Chief Operating Officer
Holding Value $5.81M 143,907 shares
Last Trade
Nov 07, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$222k 10,000 shares
$22.16
$40.39
Chinook Therapeutics
Chinook Therapeutics KDNY
Chief Operating Officer
Holding Value $6.22M 153,907 shares
Last Trade
Nov 07, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$226k 10,000 shares
$22.56
$40.39
Chinook Therapeutics
Chinook Therapeutics KDNY
Chief Operating Officer
Holding Value $5.81M 143,907 shares
Last Trade
Oct 06, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$145k 7,360 shares
$19.69
$40.39
Chinook Therapeutics
Chinook Therapeutics KDNY
Chief Operating Officer
Holding Value $6.11M 151,267 shares
Last Trade
Oct 06, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$270k 13,582 shares
$19.88
$40.39
Chinook Therapeutics
Chinook Therapeutics KDNY
Chief Operating Officer
Holding Value $549k 13,581 shares
Last Trade
Oct 06, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$270k 13,582 shares
$19.88
$40.39

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up